[ad_1]
Natural medication corporations are having fun with enormous earnings per yr due to secure enter prices in comparison with different industries.
In accordance with a latest report by SSI Analysis, natural medication companies are much less affected in a excessive inflation setting, with secure enter prices in comparison with different industries. From the monetary statements of listed pharmaceutical corporations in Viet Nam, the typical enter value of most pharmaceutical corporations stays at an identical proportion, of which 60 per cent is the price of uncooked supplies.
Though the price of uncooked supplies accounts for the biggest proportion, it’s divided into many various kinds of lively components and prescribed drugs. Consequently, the price composition of the ultimate merchandise might be very fragmented, except there’s a important disruption within the provide chain of the uncooked materials.
The opening of worldwide flights helps velocity up M&A offers. Subsequently, SSI stated that Vietnamese listed pharmaceutical corporations with a consolidated shareholder construction and the eye of overseas buyers could have a excessive valuation, making a secure funding channel for buyers within the present risky market interval.
Among the many natural medication corporations, Traphaco JSC (TRA) has all the time maintained its main place by way of revenue for many years. The everyday pharmaceutical manufacturers that Traphaco owns are Boganic, Hoat Huyet Duong Nao (nourishing mind), Tottri and Ginger Tea. In 2021, Traphaco’s income reached VND2.16 trillion, revenue after tax totaled VND264 billion (US$92.4 million), a rise of twenty-two per cent in comparison with 2020 and was the best revenue ever.
The corporate attributed the rise in revenue to strengthened monetary administration via price range planning, lowering inefficient and wasteful prices, and allocating satisfactory prices to advertise enterprise actions, make sure the completion of the annual revenue plan, rising gross sales of key merchandise, and good revenue margins.
Traphaco’s incomes per share (EPS) in 2021 was VND5,177, greater than OPC Pharmaceutical JSC (OPC) with EPS of VND4,742.
In second place was OPC Pharmaceutical JSC (OPC), in 2021, OPC’s internet income reached VND1.12 trillion, up 17 per cent over the identical interval final yr, the best ever. Revenue after tax touched a file of VND123 billion, up 20 per cent year-on-year.
Foripharm this yr ranked third after OPC Pharmaceutical JSC (OPC). When it comes to income, Foripharm earned round VND400 billion in 2021. Within the final two years in 2020 and 2021, Foripharm’s gross revenue margin has all the time stayed at 69 per cent. Foripharm attributed the excessive revenue margin to excessive proportion of gross sales of self-manufactured items, accounting for over 90 per cent. Foripharm’s dividend payout ratio was additionally the best within the trade with a money dividend of 60 per cent in 2021 and a plan of 40 per cent for 2022.
Nam Duoc JSC has a number of well-known merchandise derived from conventional natural medicines resembling Thong Xoan Tan, Nam Duoc Cough Drugs and Diabetna. In 2021, regardless of many difficulties because of the COVID-19 pandemic, NDS nonetheless reported good enterprise outcomes, particularly within the final six months of the yr when the demand for merchandise rose.
Consequently, the corporate’s income set a file since its inception, reaching VND640 billion, equal to a rise of 16 per cent over the earlier yr. Nevertheless, after-tax revenue considerably slowed down, reaching greater than VND68 billion, exceeding the set plan however lowering by greater than 5 per cent in comparison with 2020.
Not solely specializing in the core product of natural medication, Nam Duoc JSC continues to develop into the beauty section. In 2021 it began to spend money on manufacturing strains of specialied merchandise for treating endemic illnesses, resembling Emhappy Female Hygiene Resolution, Timazgel Zits Gel and Ich Nhi Bathe Gel.
The corporate stated this section was the energy of Vietnamese prescribed drugs, which have nice potential and might be a driving drive for the corporate’s growth.
Nam Ha Pharmaceutical is well-known for its cough medication merchandise and Nam Ha cough syrup. Though the constitution capital is just VND52 billion, the corporate’s income for the final 4 consecutive years was roughly VND1 trillion per yr. Nevertheless, the revenue stayed low, in 2021 the corporate achieved a revenue of VND30 billion.
bizhub
[ad_2]
Source link